LCP

Lamond Capital Partners Portfolio holdings

AUM $14.3M
This Quarter Return
+7.65%
1 Year Return
-19.1%
3 Year Return
+80.95%
5 Year Return
–
10 Year Return
–
AUM
$66.9M
AUM Growth
+$66.9M
Cap. Flow
-$13.2M
Cap. Flow %
-19.68%
Top 10 Hldgs %
100%
Holding
13
New
6
Increased
–
Reduced
1
Closed
5

Top Buys

1
ORCL icon
Oracle
ORCL
$18.3M
2
ABBV icon
AbbVie
ABBV
$17.8M
3
PBYI icon
Puma Biotechnology
PBYI
$17.3M
4
RXDX
Ignyta, Inc.
RXDX
$626K
5
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
$460K

Top Sells

1
OCUL icon
Ocular Therapeutix
OCUL
$17.3M
2
ALXN
Alexion Pharmaceuticals Inc
ALXN
$15.6M
3
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$11M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
$10.5M
5
CY
Cypress Semiconductor
CY
$9.37M

Sector Composition

1 Healthcare 72.24%
2 Technology 27.3%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ORCL icon
1
Oracle
ORCL
$635B
$18.3M 27.3%
+500,000
New +$18.3M
ABBV icon
2
AbbVie
ABBV
$372B
$17.8M 26.56%
+300,000
New +$17.8M
PBYI icon
3
Puma Biotechnology
PBYI
$254M
$17.3M 25.87%
+220,780
New +$17.3M
AMGN icon
4
Amgen
AMGN
$155B
$12.2M 18.2%
75,000
-25,000
-25% -$4.06M
RXDX
5
DELISTED
Ignyta, Inc.
RXDX
$626K 0.94%
+46,721
New +$626K
ZLTQ
6
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$460K 0.69%
+16,119
New +$460K
IMMU
7
DELISTED
Immunomedics Inc
IMMU
$307K 0.46%
+100,000
New +$307K
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$11.2B
– –
-100,000
Closed -$10.5M
OCUL icon
9
Ocular Therapeutix
OCUL
$2.12B
– –
-1,233,285
Closed -$17.3M
ALXN
10
DELISTED
Alexion Pharmaceuticals Inc
ALXN
– –
-100,000
Closed -$15.6M
GWPH
11
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-120,000
Closed -$11M
KITE
12
DELISTED
Kite Pharma, Inc.
KITE
– –
0
– –
CY
13
DELISTED
Cypress Semiconductor
CY
– –
-1,100,000
Closed -$9.37M